IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport

By rosaguerrero • July 28, 2022

Boado RJ. IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport. Pharmaceutics. 2022 Jul 15;14(7):1476. doi: 10.3390/pharmaceutics14071476. PMID: 35890374; PMCID: PMC9322584.

Tags: Alzheimer’s disease, blood–brain barrier, decoy receptors, fusion proteins, insulin receptor, lysosomal storage disorders, monoclonal antibody, neurotrophic factors, Parkinson’s disease, protein-based therapy, Publications, transferrin receptor

Diet, nutrition, and hormone therapy for prostate cancer: a systematic review with implications for future interventions

Pahulu I, Calumpit M, Tominez P, Shih JJ, Ebrahimi S, Deville NV, Samoa R, Moin T, Sedrak MS, Valle LF, Steinberg M, Kishan AU, Ganz[...]

The malate-aspartate shuttle supports thermogenic lipid mobilization in brown adipocytes

Veliova M, Ferreira CM, Montales KP, Villalobos F, Brownstein AJ, Acín-Pérez R, Ferreira GS, Jones AE, Stiles L, Divakaruni AS, Liesa M, Shirihai OS, Oliveira[...]

Regional Comparisons of the Prevalence and Socioeconomics of Hepatitis Delta Virus in Two Southern California Counties

Pak K, Leng M, Nguyen J, Moussa K, Gish R, Han SH, Pockros P. Regional Comparisons of the Prevalence and Socioeconomics of Hepatitis Delta Virus[...]